Status
Conditions
Treatments
About
To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC.
To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.
Sex
Ages
Volunteers
Inclusion criteria
Nil
Exclusion criteria
Nil
0 participants in 1 patient group
Loading...
Central trial contact
Ross Andrew Soo, MBBS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal